0001179110-18-013077.txt : 20181121 0001179110-18-013077.hdr.sgml : 20181121 20181121161247 ACCESSION NUMBER: 0001179110-18-013077 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20181119 FILED AS OF DATE: 20181121 DATE AS OF CHANGE: 20181121 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Knowlton Calvin H CENTRAL INDEX KEY: 0001685833 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-37888 FILM NUMBER: 181198341 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Tabula Rasa HealthCare, Inc. CENTRAL INDEX KEY: 0001651561 STANDARD INDUSTRIAL CLASSIFICATION: SERVICES-BUSINESS SERVICES, NEC [7389] IRS NUMBER: 465726437 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 BUSINESS PHONE: 866-648-2767 MAIL ADDRESS: STREET 1: 228 STRAWBRIDGE DRIVE STREET 2: SUITE 100 CITY: MOORESTOWN STATE: NJ ZIP: 08057 4 1 edgar.xml FORM 4 - X0306 4 2018-11-19 0 0001651561 Tabula Rasa HealthCare, Inc. TRHC 0001685833 Knowlton Calvin H 228 STRAWBRIDGE DRIVE SUITE 100 MOORESTOWN NJ 08057 1 1 0 0 Chief Executive Officer Common Stock 2018-11-19 4 S 0 1066 59.71 D 834285 I Held by spouse. Common Stock 2018-11-19 4 S 0 1636 60.76 D 832649 I Held by spouse. Common Stock 2018-11-19 4 S 0 3598 61.67 D 829051 I Held by spouse. Common Stock 2018-11-19 4 S 0 800 62.63 D 828251 I Held by spouse. Common Stock 2018-11-19 4 S 0 400 64.28 D 827851 I Held by spouse. Common Stock 2018-11-19 4 S 0 500 65.32 D 827351 I Held by spouse. Common Stock 851399 D The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by Orsula V. Knowlton on May 15, 2018. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $59.31 to $60.30, inclusive. The reporting person undertakes to provide to Tabula Rasa HealthCare, Inc., any security holder of Tabula Rasa HealthCare, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each price within the range set forth in footnotes (2), (3), (4), (5), (6) and (7) to this Form 4. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $60.31 to $61.25, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $61.32 to $62.07, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $62.29 to $62.84, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $63.86 to $64.53, inclusive. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $65.00 to $65.94, inclusive. The sales aggregated in Row 5 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein. The sales aggregated in Row 6 of Table I are not matchable under Section 16(b) of the Securities Exchange Act of 1934 against purchases at lower prices by the reporting person on November 12, 2018 because such purchases were previously matched with sales on September 7, 2018 at higher sales prices, and the reporting person has already paid to Tabula Rasa Healthcare, Inc. the full amount of profit realized in connection with the previous short-swing transactions. Thus, no further disgorgement under Section 16(b) would result from the transactions disclosed herein. /s/ Brian W. Adams, by Power of Attorney 2018-11-21